CRIS Current Research Information System

BARBATO, SIMONA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.545
NA - Nord America 883
EU - Europa 677
SA - Sud America 116
AF - Africa 71
OC - Oceania 4
Totale 3.296
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 862
VN - Vietnam 645
SG - Singapore 331
CN - Cina 325
IT - Italia 293
HK - Hong Kong 104
BR - Brasile 87
DE - Germania 80
GB - Regno Unito 63
KR - Corea 55
SE - Svezia 50
IN - India 42
NL - Olanda 39
CI - Costa d'Avorio 30
IE - Irlanda 27
RU - Federazione Russa 26
FI - Finlandia 23
FR - Francia 20
SC - Seychelles 18
JP - Giappone 13
CA - Canada 12
TG - Togo 12
AR - Argentina 11
AT - Austria 9
PL - Polonia 8
BD - Bangladesh 6
BG - Bulgaria 6
JO - Giordania 6
ZA - Sudafrica 6
CZ - Repubblica Ceca 5
EC - Ecuador 5
EE - Estonia 5
ID - Indonesia 5
MX - Messico 5
ES - Italia 4
HR - Croazia 4
TR - Turchia 4
UA - Ucraina 4
AU - Australia 3
CH - Svizzera 3
CL - Cile 3
CO - Colombia 3
IL - Israele 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
GH - Ghana 2
LT - Lituania 2
PY - Paraguay 2
RO - Romania 2
RS - Serbia 2
BO - Bolivia 1
BS - Bahamas 1
CR - Costa Rica 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
KE - Kenya 1
KN - Saint Kitts e Nevis 1
LA - Repubblica Popolare Democratica del Laos 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PE - Perù 1
QA - Qatar 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
UZ - Uzbekistan 1
ZM - Zambia 1
Totale 3.296
Salva come PNG Salva come JPEG
Città #
Singapore 224
Ho Chi Minh City 201
Hanoi 159
Bologna 134
Ashburn 129
Hefei 118
Hong Kong 103
Chandler 102
Dallas 84
Fairfield 64
Seoul 55
Southend 45
Santa Clara 38
Abidjan 30
Beijing 30
Haiphong 30
Dublin 23
Princeton 22
Los Angeles 20
Wilmington 20
Redmond 19
Houston 18
Seattle 18
Woodbridge 18
Boardman 17
Cambridge 17
Dongguan 15
Milan 14
São Paulo 14
Biên Hòa 13
Ann Arbor 12
Ha Long 12
Lomé 12
Quận Bình Thạnh 12
Bengaluru 11
New York 11
Ninh Bình 11
Thái Nguyên 11
Tokyo 11
Helsinki 10
Munich 10
Redondo Beach 10
Shenzhen 10
Hyderabad 9
Quận Một 9
Rome 9
Buffalo 8
Nanjing 8
Can Tho 7
Da Nang 7
Lappeenranta 7
Vũng Tàu 7
Amman 6
Atlanta 6
Bắc Giang 6
Bến Tre 6
Fabriano 6
Quận Phú Nhuận 6
Sofia 6
Turku 6
Vinh 6
Amsterdam 5
Bremen 5
Bắc Ninh 5
Falkenstein 5
Hải Dương 5
Mexico City 5
Nuremberg 5
Điện Bàn 5
Ankara 4
Berlin 4
Bettystown 4
Cernusco sul Naviglio 4
Curitiba 4
Florence 4
Frankfurt am Main 4
Guangzhou 4
Jakarta 4
Lang Son 4
Madrid 4
Nam Định 4
Padova 4
Quận Năm 4
Quận Tân Phú 4
Rio de Janeiro 4
San Felice sul Panaro 4
San Francisco 4
San Giovanni in Persiceto 4
Shanghai 4
Stockholm 4
Thành Phố Bà Rịa 4
Tongling 4
Turin 4
Vienna 4
Westminster 4
Wuhan 4
Bern 3
Brasília 3
Brooklyn 3
Bình Dương 3
Totale 2.222
Salva come PNG Salva come JPEG
Nome #
Clonal and subclonal TP53 molecular impairment is associated with prognosis and progression in multiple myeloma 663
Hypoxia Decreases ROS level in human fibroblasts 193
Standardization of 18F-FDG-PET/CT According to Deauville Criteria for Metabolic Complete Response Definition in Newly Diagnosed Multiple Myeloma 177
Bortezomib, thalidomide, and dexamethasone followed by double autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GIMEMA-MMY-3006): long-term follow-up analysis of a randomised phase 3, open-label study 168
Clinical Presentation and Long‐Term Survival Outcomes of Patients With Monoclonal Gammopathy of Renal Significance (MGRS): A Multicenter Retrospective Study 160
Diagnostic Innovations: Advances in imaging techniques for diagnosis and follow-up of multiple myeloma 150
Role of serum-free light chain assay for defining response and progression in immunoglobulin secretory multiple myeloma 149
Idecabtagene vicleucel (ide-cel) for the treatment of triple-class exposed relapsed and refractory multiple myeloma 141
The inhibitor protein (IF1) of the F1F0-ATPase modulates human osteosarcoma cell bioenergetics 140
Long term follow-up of humoral and cellular response to mRNA-based vaccines for SARS-CoV-2 in patients with active multiple myeloma 131
null 125
Emerging and current treatment combinations for transplant-ineligible multiple myeloma patients 107
Role of Imaging in the Evaluation of Minimal Residual Disease in Multiple Myeloma Patients 101
null 96
How I Treat High-risk Multiple Myeloma 86
Bispecific Antibodies for the Management of Relapsed/Refractory Multiple Myeloma 82
The role of the ATPase inhibitor factor 1 (IF(1)) in cancer cells adaptation to hypoxia and anoxia 80
Impact of Anti-CD38 Monoclonal Antibody Therapy on CD34+ Hematopoietic Stem Cell Mobilization, Collection, and Engraftment in Multiple Myeloma Patients—A Systematic Review 80
Antibody-drug conjugates, bispecific antibodies and CAR-T cells therapy in multiple myeloma 74
Subcutaneous bortezomib-containing regimens as up-front treatment of newly diagnosed transplant-eligible multiple myeloma patients: a retrospective, non-interventional observational study 74
Interference of daratumumab and efficacy of plerixafor on haematopoietic stem cell collection in Multiple Myeloma 72
MicroRNAs in Oncogenesis and Tumor Suppression 69
Impact of minimal residual disease standardised assessment by FDG-PET/CT in transplant-eligible patients with newly diagnosed multiple myeloma enrolled in the imaging sub-study of the FORTE trial 64
T-Cell Redirecting Therapies in Multiple Myeloma: Pathogenesis and Management of Toxicities Beyond CRS and ICANS 37
Bispecific Antibodies and CAR T in Multiple Myeloma: Appropriate Selection of Patients and Sequencing 35
Ten-year experience on home care for patients with plasma cell disorders: bringing optimal therapy home 35
Case Report: Uncommon co-occurrence of different renal histopathological entities in a patient with multiple myeloma and lymphoplasmacytic lymphoma 29
Forcing Ahead: Second-Line Treatment Options for Lenalidomide-Refractory Multiple Myeloma 26
Exceptional long-term responses from OCEAN and HORIZON trials: melflufen-dexamethasone as an expansion of treatment options for relapsed/refractory multiple myeloma in the era of new immunotherapies? 24
Correction: Forcing Ahead: Second-Line Treatment Options for Lenalidomide-Refractory Multiple Myeloma 20
Totale 3.388
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.290
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.290
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202184 0 0 0 0 0 0 2 6 11 11 9 45
2021/2022255 6 10 10 14 17 7 3 18 19 33 75 43
2022/2023330 42 46 6 52 14 31 11 16 67 10 25 10
2023/2024131 10 17 6 7 8 20 9 38 2 4 5 5
2024/2025620 26 27 52 60 57 18 41 15 25 68 75 156
2025/20261.694 299 646 195 211 195 148 0 0 0 0 0 0
Totale 3.388